Circulating B Cells With Memory and Antibody-Secreting Phenotypes Are Detectable in Pediatric Kidney Transplant Recipients Before the Development of Antibody-Mediated Rejection

Supplemental Digital Content is available in the text.

[1]  K. Kaku,et al.  Preformed C1q-binding Donor-specific Anti-HLA Antibodies and Graft Function After Kidney Transplantation. , 2018, Transplantation proceedings.

[2]  E. Han,et al.  Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients , 2018, PloS one.

[3]  I. Moxon,et al.  Components , 2018, Patterns.

[4]  J. Grinyó,et al.  Value of monitoring circulating donor‐reactive memory B cells to characterize antibody‐mediated rejection after kidney transplantation , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  Dana Pe'er,et al.  PhenoGraph and viSNE facilitate the identification of abnormal T‐cell populations in routine clinical flow cytometric data , 2018, Cytometry. Part B, Clinical cytometry.

[6]  D. Lora,et al.  Longitudinal profile of circulating T follicular helper lymphocytes parallels anti‐HLA sensitization in renal transplant recipients , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[7]  Rubin Zhang.  Donor-Specific Antibodies in Kidney Transplant Recipients. , 2018, Clinical journal of the American Society of Nephrology : CJASN.

[8]  D. Segev,et al.  Antibody‐mediated rejection: New approaches in prevention and management , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  A. Israni,et al.  OPTN/SRTR 2016 Annual Data Report: Kidney , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  M. Stegall,et al.  Comparison Between Total IgG, C1q, and C3d Single Antigen Bead Assays in Detecting Class I Complement-Binding Anti-HLA Antibodies. , 2017, Transplantation proceedings.

[11]  K. Budde,et al.  Clinical Outcome of Patients With De Novo C1q-Binding Donor-Specific HLA Antibodies After Renal Transplantation , 2017, Transplantation.

[12]  S. Brouard,et al.  Renal Operational Tolerance Is Associated With a Defect of Blood Tfh Cells That Exhibit Impaired B Cell Help , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  Benjamin D. Greenbaum,et al.  Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses , 2017, Cell.

[14]  Hai Qi.  T follicular helper cells in space-time , 2016, Nature Reviews Immunology.

[15]  G. Ghiggeri,et al.  Acquisition of C3d‐Binding Activity by De Novo Donor‐Specific HLA Antibodies Correlates With Graft Loss in Nonsensitized Pediatric Kidney Recipients , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  H. Maecker,et al.  Immune Profiles to Predict Response to Desensitization Therapy in Highly HLA-Sensitized Kidney Transplant Candidates , 2016, PloS one.

[17]  O. Toupance,et al.  One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Double-blind Randomized Placebo-controlled Trial , 2016, Transplantation.

[18]  P. Nickerson,et al.  Non-Complement-Binding De Novo Donor-Specific Anti-HLA Antibodies and Kidney Allograft Survival. , 2016, Journal of the American Society of Nephrology : JASN.

[19]  M. Pascual,et al.  The Challenge of Acute Antibody-Mediated Rejection in Kidney Transplantation. , 2016, Transplantation.

[20]  A. Israni,et al.  Kidney , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[21]  J. Grinyó,et al.  Preformed circulating HLA-specific memory B cells predict high risk of humoral rejection in kidney transplantation. , 2015, Kidney international.

[22]  Sean C. Bendall,et al.  Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis , 2015, Cell.

[23]  Kimberly A. Thomas,et al.  The perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejection. , 2015, Trends in molecular medicine.

[24]  D. Roelen,et al.  Follicular T helper cells and humoral reactivity in kidney transplant patients , 2015, Clinical and experimental immunology.

[25]  E. Rosser,et al.  Regulatory B cells: origin, phenotype, and function. , 2015, Immunity.

[26]  D. Hesselink,et al.  Intra-patient variability in tacrolimus exposure: causes, consequences for clinical management. , 2015, Transplantation reviews.

[27]  Philip D. Hodgkin,et al.  The generation of antibody-secreting plasma cells , 2015, Nature Reviews Immunology.

[28]  T. Kurosaki,et al.  Memory B cells , 2015, Nature Reviews Immunology.

[29]  J. Scoazec,et al.  Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss. , 2015, Journal of the American Society of Nephrology : JASN.

[30]  A. Chong,et al.  Memory B cells in transplantation. , 2015, Transplantation.

[31]  X. Jouven,et al.  Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts. , 2015, Journal of the American Society of Nephrology : JASN.

[32]  K. Takeda,et al.  Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation. , 2014, Immunity.

[33]  S. Daburon,et al.  Deciphering Complement Interference in Anti–Human Leukocyte Antigen Antibody Detection With Flow Beads Assays , 2014, Transplantation.

[34]  G. Ghiggeri,et al.  DQ molecules are the principal stimulators of de novo donor‐specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplant , 2014, Transplant international : official journal of the European Society for Organ Transplantation.

[35]  T. Gelder.  Within-patient variability in immunosuppressive drug exposure as a predictor for poor outcome after transplantation , 2014 .

[36]  D. Segev,et al.  National Trends Over 25 Years in Pediatric Kidney Transplant Outcomes , 2014, Pediatrics.

[37]  D. Rush,et al.  Banff 2013 Meeting Report: Inclusion of C4d‐Negative Antibody‐Mediated Rejection and Antibody‐Associated Arterial Lesions , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[38]  Rubin Zhang,et al.  Essential concept of transplant immunology for clinical practice. , 2013, World journal of transplantation.

[39]  X. Jouven,et al.  Complement-binding anti-HLA antibodies and kidney-allograft survival. , 2013, The New England journal of medicine.

[40]  D. Tarlinton,et al.  Diversity Among Memory B Cells: Origin, Consequences, and Utility , 2013, Science.

[41]  C. Haisch,et al.  The Role of Immunoglobulin-G Subclasses and C1q in De Novo HLA-DQ Donor-Specific Antibody Kidney Transplantation Outcomes , 2013, Transplantation.

[42]  C. Akdis,et al.  IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. , 2013, The Journal of allergy and clinical immunology.

[43]  W. Hörl,et al.  Solid phase detection of C4d‐fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients , 2013, Transplant international : official journal of the European Society for Organ Transplantation.

[44]  C. Roufosse,et al.  Preformed Complement-Activating Low-Level Donor-Specific Antibody Predicts Early Antibody-Mediated Rejection in Renal Allografts , 2013, Transplantation.

[45]  W. Hop,et al.  Intra‐patient variability in tacrolimus trough concentrations and renal function decline in pediatric renal transplant recipients , 2012, Pediatric transplantation.

[46]  J. Alcocer-Varela,et al.  De Novo Donor-Specific HLA Antibody Development and Peripheral CD4+CD25high Cells in Kidney Transplant Recipients: A Place for Interaction? , 2012, Journal of transplantation.

[47]  P. Nickerson,et al.  Evolution and Clinical Pathologic Correlations of De Novo Donor‐Specific HLA Antibody Post Kidney Transplant , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[48]  S. Sutherland,et al.  Complement‐fixing donor‐specific antibodies identified by a novel C1q assay are associated with allograft loss , 2012, Pediatric transplantation.

[49]  D. Kuypers,et al.  Diagnosis and prevention of chronic kidney allograft loss , 2011, The Lancet.

[50]  D. Tyan,et al.  Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads. , 2011, Human immunology.

[51]  K. Lamb,et al.  Solid Organ Allograft Survival Improvement in the United States: The Long‐Term Does Not Mirror the Dramatic Short‐Term Success , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[52]  K. Lamb,et al.  Long‐Term Renal Allograft Survival in the United States: A Critical Reappraisal , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[53]  S. Busque,et al.  C1q-Fixing Human Leukocyte Antigen Antibodies Are Specific for Predicting Transplant Glomerulopathy and Late Graft Failure After Kidney Transplantation , 2011, Transplantation.

[54]  L. Sharples,et al.  Predicting HLA Class II Alloantigen Immunogenicity From the Number and Physiochemical Properties of Amino Acid Polymorphisms , 2011, Transplantation.

[55]  Dominique Charron,et al.  Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. , 2010, Journal of the American Society of Nephrology : JASN.

[56]  D. Rush,et al.  Evidence for Antibody-Mediated Injury as a Major Determinant of Late Kidney Allograft Failure , 2010, Transplantation.

[57]  Ethan M Balk,et al.  KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. , 2010, Kidney international.

[58]  H. T. ten Hulscher,et al.  Long-term presence of memory B-cells specific for different vaccine components. , 2009, Vaccine.

[59]  S. Deaglio,et al.  CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival. , 2005, Blood.

[60]  R. Ahmed,et al.  Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. , 2004, Journal of immunological methods.

[61]  J. Schold,et al.  Lack of Improvement in Renal Allograft Survival Despite a Marked Decrease in Acute Rejection Rates Over the Most Recent Era , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[62]  S. Deaglio,et al.  CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells. , 2003, Blood.

[63]  P. Dyer,et al.  Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome1 , 2003, Transplantation.

[64]  E. Butcher,et al.  Separable effector T cell populations specialized for B cell help or tissue inflammation , 2001, Nature Immunology.

[65]  M. McHeyzer-Williams,et al.  B cell memory and the long-lived plasma cell. , 1999, Current opinion in immunology.

[66]  T. Walley,et al.  Outcomes , 1995, Too Many Lawyers?.

[67]  J. Banchereau,et al.  Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by rapid up-regulation of B7-1 and B7-2. , 1995, Immunity.

[68]  S. Zupo,et al.  CD38 signaling by agonistic monoclonal antibody prevents apoptosis of human germinal center B cells , 1994, European journal of immunology.

[69]  M. Zaccolo,et al.  Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation. , 1990, Journal of immunology.

[70]  P. Lipsky,et al.  Human peripheral blood B lymphocyte subpopulations: functional and phenotypic analysis of surface IgD positive and negative subsets. , 1986, Journal of immunology.

[71]  G. Schwartz,et al.  A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine , 2004 .

[72]  E. Reed,et al.  Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury. , 2013, Methods in molecular biology.

[73]  橋本光男,et al.  腎移植におけるDSA(Donor specific antibody)陽性症例の検討 , 2008 .

[74]  S. Jacquot.  CD27/CD70 interactions regulate T dependent B cell differentiation , 2000, Immunologic research.